busulfan has been researched along with Becker Muscular Dystrophy in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To analyze a Duchenne muscular dystrophy(DMD) patient's muscular regeneration, dystrophin expression and locomotive variation before and after he underwent umbilical cord blood stem cell transplantation in order to assess the therapeutic effect." | 1.33 | [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation]. ( Chen, C; Chen, W; Fang, JP; Feng, HY; Feng, SW; Huang, K; Huang, SL; Li, Y; Li, Z; Liu, Y; Lu, XL; Wen, JM; Xi, J; Xiao, LL; Xie, YM; Xu, HG; Yao, XL; Ye, X; Zeng, Y; Zhang, C; Zhang, M; Zhang, WX; Zhou, DH, 2005) |
| "Currently, Duchenne muscular dystrophy (DMD) patients are treated with chronic immunosuppression for muscle precursor cell transplantation (MT)." | 1.33 | Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use. ( Bouchentouf, M; Camirand, G; Mills, P; Pichavant, C; Rothstein, D; Stephan, L; Tagmouti, S; Tremblay, JP, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, C | 1 |
| Feng, HY | 1 |
| Huang, SL | 1 |
| Fang, JP | 1 |
| Xiao, LL | 1 |
| Yao, XL | 1 |
| Chen, C | 1 |
| Ye, X | 1 |
| Zeng, Y | 1 |
| Lu, XL | 1 |
| Wen, JM | 1 |
| Zhang, WX | 1 |
| Li, Z | 1 |
| Feng, SW | 1 |
| Xu, HG | 1 |
| Huang, K | 1 |
| Zhou, DH | 1 |
| Chen, W | 1 |
| Xie, YM | 1 |
| Xi, J | 1 |
| Zhang, M | 1 |
| Li, Y | 1 |
| Liu, Y | 1 |
| Stephan, L | 1 |
| Pichavant, C | 1 |
| Bouchentouf, M | 1 |
| Mills, P | 1 |
| Camirand, G | 1 |
| Tagmouti, S | 1 |
| Rothstein, D | 1 |
| Tremblay, JP | 1 |
2 other studies available for busulfan and Becker Muscular Dystrophy
| Article | Year |
|---|---|
[Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Topics: Alprostadil; Busulfan; Child; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclo | 2005 |
Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use.
Topics: Animals; Animals, Newborn; Busulfan; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; | 2006 |